These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 3891856

  • 1. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC, Song CW, Blazar BR, Vallera DA.
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [Abstract] [Full Text] [Related]

  • 2. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K, Uchimaru K, Takahashi S, Tani K, Tojo A, Asano S.
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [Abstract] [Full Text] [Related]

  • 3. Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2004 Nov; 32(11):1110-7. PubMed ID: 15539090
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Nov; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 6. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST.
    J Immunol; 1996 Oct 01; 157(7):2820-9. PubMed ID: 8816385
    [Abstract] [Full Text] [Related]

  • 7. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2008 Dec 01; 36(12):1750-9. PubMed ID: 18809241
    [Abstract] [Full Text] [Related]

  • 8. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2003 Jul 15; 76(1):216-24. PubMed ID: 12865813
    [Abstract] [Full Text] [Related]

  • 9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 15; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 10. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E, Or R, Naparstek E, Zeira E, Slavin S.
    Bone Marrow Transplant; 1988 Mar 15; 3(2):129-40. PubMed ID: 3048477
    [Abstract] [Full Text] [Related]

  • 11. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 12. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M.
    Biol Blood Marrow Transplant; 2001 Dec 15; 7(12):646-55. PubMed ID: 11787527
    [Abstract] [Full Text] [Related]

  • 13. Booster irradiation to the spleen following total body irradiation. A new immunosuppressive approach for allogeneic bone marrow transplantation.
    Lapidot T, Singer TS, Salomon O, Terenzi A, Schwartz E, Reisner Y.
    J Immunol; 1988 Oct 15; 141(8):2619-24. PubMed ID: 3049814
    [Abstract] [Full Text] [Related]

  • 14. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M.
    Biol Blood Marrow Transplant; 1999 Oct 15; 5(3):133-43. PubMed ID: 10392959
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Oct 15; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 17. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H, Chilton PM, Huang Y, Schanie CL, Yan J, Ildstad ST.
    Transplantation; 2007 Apr 15; 83(7):954-63. PubMed ID: 17460568
    [Abstract] [Full Text] [Related]

  • 18. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST, Wren SM, Bluestone JA, Barbieri SA, Stephany D, Sachs DH.
    J Immunol; 1986 Jan 15; 136(1):28-33. PubMed ID: 2933464
    [Abstract] [Full Text] [Related]

  • 19. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
    Soiffer RJ, Mauch P, Tarbell NJ, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Murrey CI, Coral F, Bosserman L.
    Bone Marrow Transplant; 1991 Jan 15; 7(1):23-33. PubMed ID: 2043874
    [Abstract] [Full Text] [Related]

  • 20. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD, Drobyski WR, Truitt RL.
    Bone Marrow Transplant; 1993 Apr 15; 11(4):329-36. PubMed ID: 8485480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.